We are proud to announce our new partnership with Imbio, an American-based company leader in fully automated AI image analysis for acute and chronic pulmonary and cardiothoracic conditions.
Our upcoming LUNG-NOTE app will feature Imbio’s Lung Density Analysis™ (LDA) and Lung Texture Analysis™ (LTA), allowing clinicians to quickly visualize a patient’s lungs to support diagnosis and treatment decisions for a variety of patient conditions including COPD/emphysema and fibrotic disease.
"Our mission to digitize the field of Medicine has always been clear to us. By integrating both Imbio’s Lung Texture and Density Analysis, we are now moving MEDICAL-NOTE to the next level”, said Stefano Palma, General Manager at MEDICAL-NOTE.
Imbio will participate, along with MEDICAL-NOTE, at the 37th Italian Society of Thoracic Surgery (SICT) National Congress in L’Aquila (Italy), September 30th through October 2nd.